Opinion
Medical Device Network on MSNOpinion
The biggest opportunity to improve lung cancer survival isn’t a new drug
Chris Wood, CEO of RevealDx, reflects on the role AI-based characterisation of nodules (CADx) has to play in improving lung cancer survival rates.
On July 14, 2026, the Centers for Medicare & Medicaid Services (CMS) announced the CY 2027 Medicare Physician Fee Schedule proposed rule, which ...
Mega-scale exome sequencing of 1,032,116 people identified 59 independent genes linked to the TG:HDL ratio, including 44 rare ...
Taking key steps ahead of time can help you qualify for better rates ...
OpenAI unifies paid ChatGPT on Sol as Microsoft, GitHub and enterprise users scrutinize AI consumption and cost.
Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI ...
Nuclear medicine (NM) educators face a pivotal time of rapid scientific innovation and expansion of theranostic possibilities, rising volumes, staffing shortages, and a call for more high-quality ...
I talk to a lot of people who’ve been thinking about a healthcare career change for years but never actually […] ...
A 72-year-old man with chronic obstructive pulmonary disease (COPD) is admitted to a medical unit with pneumonia. Overnight, his oxygen requirement increases from 4 L/min via nasal cannula to ...
But the finished note was only ever a starting point — a trajectory the company signaled early on. Care Signals, which Abridge is naming publicly for the first time as it launches, is its clearest ...
A panel discussion at the Association for Diagnostics & Laboratory Medicine this week tackled questions around coding, reimbursement, and regulation of AI-based tests.
NI is moving Nigel AI from adviser to code author and, by 2027, workflow orchestrator, as questions grow around validation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results